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ABSTRACT The substrates of ubiquitin-dependent prote-
olytic pathways include both damaged or otherwise abnormal
proteins and undamaged proteins that are naturally short-
lived. Few specific examples of the latter class have been
identified, however. Previous work has shown that the cell
type-specific MATa2 repressor of the yeast Saccharemyces
cerevisiae is an extremely short-lived protein. We now demon-
strate that a2 is conjugated to ubiquitin in vivo. More than one
lysine residue of a2 can bejoined to ubiquitin, and some of the
ubiquitin moieties form a Lys48-linked multiubiquitin chain.
Overexpression of degradation-impaired ubiquitin variants
was used to show that at least a ficant fraction of a2
degradation is dependent on its ubiquitination.
The temporal control of many cellular processes involves
short-lived regulators. Proteins that are either conditionally
or constitutively short-lived in vivo include cell cycle regu-
lators such as the cyclins (1) and proteins controlling cell
differentiation and embryonic development (2-5).
A distinct class of intracellular proteolytic pathways in-
volves the covalent ligation of a 76-residue protein, ubiquitin
(Ub), to the E-amino groups of acceptor proteins, which are
thereby marked for degradation (6). Ub-protein conjugation
is catalyzed by a family of Ub-conjugating enzymes, also
called E2 enzymes (7). For many short-lived intracellular
proteins, their conjugation to Ub is apparently essential for
their degradation (8, 9). At the same time, the only specific
examples of naturally short-lived proteins whose degradation
appears to involve ubiquitination are the phytochrome pho-
toreceptor of plants (10) and cyclins, a family of cell cycle
regulators (11).
Our recent studies of short-lived proteins included the cell
type-specific transcriptional repressor MATa2 of the yeast
Saccharomyces cerevisiae (3). This eukaryote has two hap-
loid cell types, a and a, which can mate to form an a/a diploid
(12). Ultimately, cell identity is determined by the mating-
type, or MAT, locus. In homothallic S. cerevisiae strains,
unexpressed a or a information at two other genomic sites is
copied into the MAT locus during a mating-type switch.
Interconversion between a and a cell types can occur in <90
min. Selective protein degradation might underlie the mating-
type switch by causing rapid disappearance of the regulatory
proteins involved once their synthesis has ceased.
Indeed, the a2 repressor, encoded by the MATa locus and
involved in the repression of a cell-specific genes in a cells
and of haploid cell-specific genes in a/a diploids, has an in
vivo half-life of only -5 min at 30°C (3). Both the amino-
terminal and the carboxyl-terminal domains of a2 contain
regions that can act as autonomous degradation signals; these
signals operate via genetically distinguishable pathways (3).
We now demonstrate, using epitope-tagged forms of ubiq-
uitin, that a2 is ubiquitinated in vivo. We also show that
ubiquitination of a2 contributes to its rapid degradation.
MATERIALS AND METHODS
Yeast Strains and Media. The S. cerevisiae strains used
were DBY1705 (MATa leu2-3,112 ura3-S2 lys2-801 gal2),
DBY1829 (MATa leu2-3,112 ura3-52 lys2-801 his3-A200 trpl-
1), HR125-5Dalf [A(MATa): :CANJ-14 leu2-3,112 ura3-S2
trpl his3 his4] (3), and YPH500 (MATa ura3-52 lys2-801
ade2-101 trpl-A63 his3-A200 leu2-Al) (13). Yeast media were
prepared as described (3). For induction of CUP] promoter-
dependent Ub alleles, CuSO4 was added (0.1 mM) 4-7 hr
before radiolabeling.
Plasmids. The plasmid used for constructing site-specific
Ub mutants was YEp96, a 2-,um-based S. cerevisiae-
Escherichia coli shuttle vector that contains a synthetic
version of the 76-residue yeast Ub coding sequence under the
control of the copper-inducible CUP] promoter (14).
YEp1O5, encoding a c-myc epitope attached to the amino
terminus of Ub, will be described elsewhere (M.J.E. and
M.H.; see Fig. 1B). YEp11O encodes yeast Ub with an
arginine (instead of lysine) at position 48 (Ub-R48). YEp112,
encoding an epitope from the hemagglutinin (ha) of influenza
virus (15) attached to the amino terminus ofUb (Fig. 1B), was
constructed as follows. Complementary 55-mer synthetic
oligodeoxynucleotides encoding the ha extension were an-
nealed to generate a double-stranded fragment with EcoRI
and Bgl II adhesive ends that could be ligated into the
EcoRI/Bgl II-cut Ub gene ofYEp%. The synthetic fragment
contained an Nhe I site to facilitate screening for the frag-
ment's insertion. YEp113 was constructed similarly to
YEp112 except that the parental plasmid was YEp110, re-
sulting in a ha-tagged, Arg'8-substituted Ub variant (haUb-
R48). For unknown reasons, the ha-tagged Ub was expressed
at lower levels than the myc-tagged Ub (data not shown).
Under the conditions described below and in ref. 3, 40-60%6
of the ha-tagged Ub conjugates were precipitated from yeast
extracts with the anti-ha monoclonal antibody. In the exper-
iments shown in Fig. 3, the human Ub gene (in YEp9O) and
its Ub-R48 allele (in YEp94) were used. Qualitatively similar
results were obtained with the corresponding yeast Ub alleles
(data not shown).
The mutant a2 repressor, with Lys -* Arg substitutions at
positions 107 and 109, was produced by oligonucleotide-
directed mutagenesis of the MATa2 gene using M13mpl9
(16). The mutated gene was transferred into YEplacl95 (17),
which was then transformed into HR125-5Dalf S. cerevisiae
that also harbored either YEp96 or YEp1O5.
Abbreviations: Ub, ubiquitin; ha, hemagglutinin; Pgal, P-galacto-
sidase.
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Immunoprecipitation and Pulse-Chase Assays. For immu-
noprecipitation of a2, an anti-a2 antibody affinity-purified
against a2 produced in E. coli was used (3). The 12CA5
monoclonal antibody against the ha epitope and the mono-
clonal antibody to E. coli,(-galactosidase (JSgal) have been
described (15, 18). Exponentially growing yeast cells were
labeled for 5 min at 300C with Tran35S-label (ICN) [for the
experiment in Fig. LA, [3H]-leucine (Amersham) was used],
harvested by centrifugation, and disrupted by mixing with an
equal volume of 2% SDS/30 mM dithiothreitol/90 mM Na
Hepes, pH 7.5, and incubating for 3 min at 1000C. In the
experiments with Ub-Pro-fBgal, cells were disrupted by vor-
tex mixing with glass beads (3). Other aspects of the proce-
dures used for cell lysis, immunoprecipitation, and pulse-
chase analysis were as described (3). In the experiments with
a2 described here, cells carried MATa on a high-copy
plasmid. For the serial immunoprecipitations in Fig. 2, pro-
teins of the first immunoprecipitate were eluted from the
protein A-agarose beads (Repligen) by incubating the beads
(5 ,ul) in 50 ,ul of 1% SDS/50 mM Na Hepes, pH 7.5, at 100°C
for 2 min. The eluate was diluted 20-fold with 1% (vol/vol)
Triton X-100/0.15 M NaCl/5 mM Na EDTA/50 mM Na
Hepes, pH 7.5, containing protease inhibitors (see ref. 3).
Ascitic fluid (2 ILI) containing the 12CA5 antibody to the ha
epitope was then added, and ha-containing proteins were
precipitated (3). Unless stated otherwise, a2 and Ub-Pro-j3gal were analyzed by electrophoresis in 12% and 6% poly-
acrylamide/SDS gels, respectively.
RESULTS
The a2 Repressor Is Ubiquitinated in Vivo. Ub-dependent
degradation of a protein involves the formation of transient
Ub-protein conjugates (6). When the short-lived a2 repressor
was pulse-labeled and immunoprecipitated with an affinity-
purified anti-a2 antibody (3) from SDS extracts of S. cere-
visiae cells that expressed a2 from a high-copy plasmid, one
or more minor labeled species larger than a2 could be
detected in the precipitate (Fig. LA, arrows). That these high
molecular mass species contained a2 was indicated by the
correlation of their levels with the level of a2 in the cell and
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by their absence from anti-a2 precipitates produced with
extracts from a cells (data not shown). In addition, mutation
ofcertain residues in a2 altered the electrophoretic pattern of
the high molecular mass species (see below). Although these
putative Ub-a2 conjugates could not be detected by immu-
noblot analysis with polyclonal antibodies to Ub (data not
shown), it remained possible that this method was insuffi-
ciently sensitive to detect short-lived Ub-a2 conjugates.
We previously constructed a Ub mutant in which the amino
terminus of yeast Ub was extended by a 13-residue peptide
containing an epitope from the human c-myc protein (20).
This Ub variant (mycUb) is indistinguishable from wild-type
Ub in its ability to be enzymatically conjugated to and
cleaved from acceptor proteins (M.J.E. and M.H., unpub-
lished data). The mycUb is =1.5 kDa larger than wild-type
Ub. If the high molecular mass species present in the a2
immunoprecipitates (Fig. lA) were Ub-a2 conjugates, in vivo
substitution of Ub with the larger mycUb should lead to a
decrease in electrophoretic mobility of these species but not
of unmodified a2.
Fig. 1C shows SDS/PAGE patterns of a2 immunoprecip-
itates from pulse-labeled cells that carried either YEp96(wild-type Ub) or YEp1O5 (mycUb). Levels of mycUb ex-
pressed from the CUP) promoter of YEp1O5 in cells grown
in the absence or presence ofadded copper ions were %2-fold
and 4100-fold higher, respectively, than the levels of wild-
type Ub expressed in the same cells from the four genes
UBIl-UBI4 (21) (M.J.E. and M.H., unpublished data). Com-
parison of lanes 2 and 3 in Fig. 1C showed that the putative
monoubiquitinated a2 species was largely replaced by an
a2-containing protein -1.5 kDa larger when mycUb was
expressed at high levels (Ub-a2 vs. mUb-a2). Moreover, a
second, larger species, presumed to be a doubly ubiquitinated
a2 (Ub2-a2), also migrated more slowly when derived from
cells overproducing mycUb (mUb2-a2; Fig. 1C, lanes 2 and
3). These and other experiments (see Fig. 5) indicated that
overexpression of mycUb was accompanied by increases in
size of at least three higher molecular mass, a2-containing
species (or groups of species; see below). We conclude that
the a2 repressor is ubiquitinated in vivo and that it is
conjugated to multiple Ub moieties. (These experiments
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FiG. 1. The a2 repressor is ubiquitinated in vivo. (A) Immunoprecipitation with antibody to a2 yields, in addition to a2, a set of higher
molecular mass species (arrows). DBY1705 cells carrying a high-copy MATa plasmid were pulse-labeled for 5 min, followed by extraction,
immunoprecipitation, and SDS/15% PAGE. (B) Epitope-tagged forms of ubiquitin used to examine a2 ubiquitination. The epitopes from human
c-myc and influenza virus hemagglutinin (ha) are underlined. (C) Expression of mycUb (mUb) in DBY1829 cells leads to an increase in the
apparent molecular masses of the putative Ub-a2 conjugates seen in A. The anomalously slow migration of the doubly ubiquitinated species(Ubra2) is similar to that seen with other proteins modified by a multi-Ub chain (19; Fig. 2B). Heterogeneity of the ubiquitinated a2 species
is also evident; a clear example is the minor mycUb-a2 band marked by an arrowhead in lane 3. Molecular masses (in kilodaltons) of marker
proteins are indicated.
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made use of a2 expressed from a high-copy MATa plasmid;
similar results were obtained with a2 expressed from the
single-copy chromosomal MATa locus (data not shown)].
Another feature of Fig. 1C (lane 4) is the presence of
approximately equal amounts of the mycUb-a2 and Ub-a2
species (as well as mycUb2-a2 and Ub2-a2) in uninduced
cells, which express comparable amounts of wild-type Ub
and mycUb. Thus, the relative levels of the Ub- and mycUb-
containing a2 conjugates approximated the relative levels of
Ub and mycUb in the cell. Note that the set of Ub-a2
conjugates is more heterogeneous than is apparent from the
above discussion; see, for instance, the additional, unas-
signed mycUb-a2 species indicated by an arrowhead in Fig.
1C, lane 3. This heterogeneity could be due to incomplete
denaturation of conjugates by SDS and/or to the presence of
minor alternative sites of Ub attachment within a2 (see
below).
Multiply Ubiquitinated a2 Contains a Lys48-Linked
Multi-Ub Chain. Multiple Ub moieties could be joined to the
a2 protein in several distinct ways, illustrated in Fig. 2A for
a Ub3-ca2 conjugate. Experiments with an in vitro proteolytic
system from rabbit reticulocytes have shown that degrada-
tion of proteins by the N-end rule pathway [a Ub-dependent
pathway (18) whose substrates do not include ac2 (3)] requires
formation of a multi-Ub chain on a targeted protein (19). In
this chain, several Ub moieties attach sequentially to an
initial acceptor protein to form a branched Ub-Ub structure
in which the carboxyl-terminal Gly76 of one Ub is joined to
the e-amino group of the Lys'8 in the adjacent Ub moiety.
Substitution of an arginine residue for Lys' in Ub does not
perturb the ability of Ub-R48 to be conjugated to other
proteins but renders it unable to serve as an acceptor protein
within the multi-Ub chain (19). The Ub-R48 mutant is there-
fore an efficient terminator of multi-Ub chain formation.
To ascertain whether the multiply ubiquitinated ac2 deriv-
atives contain a Lys'-linked multi-Ub chain, we first tagged
both wild-type Ub and its Ub-R48 variant with an epitope
from the ha of influenza virus (Fig. 1B Bottom). This epitope
is recognized by the high-avidity monoclonal antibody 12CA5
(15). (An alternative epitope tag was necessary because of
inefficient precipitation of myc-tagged proteins by the anti-
myc antibody.) The utility of the ha-tagged Ub variants for
analyzing the structure of Ub-protein conjugates was tested
with a Ub-Pro-fgal fusion protein, a previously characterized
substrate of the Ub system (18). Ub-Pro-p3gal is short-lived
due to formation of a multi-Ub chain on Lys' of the amino-
terminal Ub moiety (ref. 19; E. Johnson and A.V., unpub-
lished results). [The presence of proline at the Ub-,Bgal
junction inhibits the in vivo removal of the amino-terminal Ub
(18, 19).] Extracts from pulse-labeled cells expressing Ub-
Pro-jPgal and haUb were precipitated with an antibody tof3gal; the precipitated proteins were then dissolved and
precipitated with the anti-ha antibody. SDS/PAGE of the
second precipitate showed it to contain a series of labeled
species larger than Ub-Pro-,3gal itself (Fig. 2B, lane 2).
Because none of these species were seen in the identically
obtained anti-ha precipitate from pulse-labeled cells express-
ing Ub-Pro-,3gal and wild-type Ub (Fig. 2B, lane 3), we
conclude that the series of bands in Fig. 2B, lane 2, represent
multiply ubiquitinated Ub-Pro-f3gal derivatives.
Formation of multiply ubiquitinated Ub-Pro-fgal was sup-
pressed in cells expressing haUb-R48 (the multi-Ub chain-
terminating Ub variant; see above) (Fig. 2B, lane 1), while
levels of the unmodified Ub-Pro-,3gal were virtually the same
in all of these experiments (data not shown). The Ub moieties
of the multiply ubiquitinated Ub-Pro-,3gal have been shown,
by direct structural analysis, to form a Lys'-linked multi-Ub
chain (19). The suppression of multi-Ub chain formation by
the haUb-R48 mutant (Fig. 2B, lane 1), in addition to sup-
porting the earlier conclusions (19), validates the use of this
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FIG. 2. Evidence for a branched multi-Ub chain in the multiply
ubiquitinated a2 protein. (A) Three ways in which three Ub mole-
cules (black ovals) could be conjugated to an acceptor protein
(rectangle). (B) Use of ha-tagged Ub to mark ubiquitinated deriva-
tives of Ub-Pro-,Bgal (Ub-P-fgal). Proteins from extracts of pulse-labeled YPH500 cells were precipitated with an antibody to )9gal,dissolved, and reprecipitated with an anti-ha antibody. Extracts were
made from cells expressing Ub-Pro-,8gal and haUb-R48 (lane 1),
haUb (lane 2), or Ub (lane 3). The minor multiubiquitinated species
that did form in cells expressing haUb-R48 had aberrant mobilities
(lane 1 vs. lane 2); thus, in the absence of Lys', formation of Ub-Ub
linkages may occur at a low rate through one or more of the other six
lysines of Ub. A small fraction of Ub-Pro-pgal is visible on the gel,
presumably precipitated by anti-pgal antibody that survived the SDS
elution step. Multiply ubiquitinated haUb"-(Ub-Pro-Pgal) species are
marked by a bracket. (C) Detection of Ub in anti-a2 precipitates and
suppression of multiply ubiquitinated a2 species by the haUb-R48
mutant. Only antibody to a2 was used with extracts from pulse-
labeled HR125-5Dalf cells (carrying a high-copy MATa plasmid) in
lane 1 (wild-type Ub) and lane 2 (haUb), while anti-ha antibody was
used to reprecipitate proteins eluted from anti-a2 precipitates in lane
3 (Ub), lane 4 (haUb), and lane 5 (haUb-R48). A small fraction of
unmodifieda2 present in the latter three lanes was due to either a
small amount of anti-a2 antibody surviving the SDS elution step or
sample spillage from lanes 1 or 2.
mutant as a probe for the presence of multi-Ub chains in other
proteins.
Experiments identical in design to those with Ub-Pro-p3gal
were performed with the a2 repressor and yielded similar
results. Specifically, when a2-expressing cells contained
exclusively wild-type Ub, noa2-containing species could be
precipitated (from a dissolvedac2 immunoprecipitate) by the
anti-ha antibody (Fig. 2C, lane 3). However, an otherwise
identical experiment with cells expressing high levels ofhaUb
yielded a number of species larger thanac2 after precipitation
by the anti-ha antibody from the dissolveda2 immunopre-
cipitate (Fig. 2C, lane 4). These results provided independent
Proc. NatL Acad. Sci. USA 88 (1991)
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evidence that the high molecular mass, a2-containing pro-
teins were Ub conjugates, a conclusion reached above
through the use of the myc-tagged Ub (Fig-. 1). When cells
expressed both a2 and high levels of haUb-R48, formation of
the doubly ubiquitinated a2 species was suppressed relative
to that of the monoubiquitinated a2 (Fig. 2C, lanes 4 vs. 5),
indicating the presence of Ub-Ub linkages in the doubly
ubiquitinated species. We conclude that at least some of the
Ub moieties in multiply ubiquitinated a2 derivatives occur as
a Lys'-linked multi-Ub chain.
Ubiquitin and a2 Degradation. Earlier in vitro evidence
indicated that formation of a multi-Ub chain is required for
the degradation of substrates of the N-end rule pathway (19).
To address a possible role for the multi-Ub chain in the
degradation of a2 [which is not an N-end rule substrate (3)],
we measured the effect of the chain-terminating Ub-R48
mutant on the metabolic stability of a2. The in vivo half-life
of a2 was increased -2-fold in cells expressing high levels of
Ub-R48 (in addition to wild-type Ub, expressed from the
chromosomal UBII-UBI4 genes) (Fig. 3). Control experi-
ments (data not shown) indicated that the inhibition of a2
degradation by Ub-R48 was not due to the CuS04 added to
induce the CUPI promoter-mediated expression of Ub-R48
(see also Fig. 4). Furthermore, expression ofUb-R48 resulted
in a >2-fold increase in the relative amount of 35S in the
pulse-labeled monoubiquitinated a2 species (from <1% to
nearly 2% of 35S in the unmodified ac2 species) (compare Fig.
3 A and B). A similar increase was seen in the analogous
experiments with the ha-tagged Ub-R48 mutant (Fig. 2C, lane
4 vs. lane 5). Thus, while monoubiquitination of a2 is
unimpaired in the presence of Ub-R48, further Ub additions
are inhibited, as is the degradation of ac2.
We recently found that myc-tagged Ub (mycUb) also
inhibits Ub-dependent protein degradation. However, in
contrast to Ub-R48, which is a multi-Ub-chain terminator,
mycUb acts by inhibiting the degradation of multi(mycUb)-
chain-bearing substrates (M.J.E. and M.H., unpublished
results). We therefore examined the effect of mycUb on a2
degradation (Fig. 4). The half-life of a2 increased almost
2-fold (from -6 min to =11 min) in cells expressing high
levels of mycUb (Fig. 4). Since in all of these experiments
cells also contained considerable amounts of wild-type Ub,
the inhibition of ac2 degradation by either Ub-R48 or mycUb
was expected to be "leaky." Thus, the observed degree of
inhibition of a2 degradation by either mycUb or Ub-R48
suggests that at least a significant fraction of a2 turnover
occurs via one or more Ub-dependent pathways.
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Multiple Ubiquitination Sites in a2. The data of Figs. 1C and
2C suggested that more than one lysine of ac2 can be joined to
Ub. Cyanogen bromide peptide mapping of Ub-a2 conjugates
(M.H., unpublished data) suggested that at. least one Ub
attachment site is located in the region linking the two globular
domains of the a2 protein. A double Lys -- Arg substitution
in this region (positions 126 and 129) had no effect on ac2
ubiquitination or degradation (data not shown). Substitution of
arginines for the remaining two lysines within the linker region
(positions 107 and 109) eliminated a minor Ub-a2 species seen
with wild-type a2 (Fig. 5). Thus, either Lys107 or Lys109 is
likely to serve as a minor ubiquitination site in a2. The
function, if any, of this site is unknown. Its elimination did not
alter the half-life of a2, and cells expressing the mutant a2
protein (a2-R107,109) continued to mate as a cells; the result-
ant diploids sporulated normally (data not shown).
DISCUSSION
We have shown that the MATa2 repressor of S. cerevisiae is
multiply ubiquitinated in vivo, that some of the Ub moieties
form a Lys'8-linked multi-Ub chain, and that ubiquitination of
ar2 contributes to its metabolic instability. Although the set of
naturally short-lived proteins known to be degraded via
Ub-dependent pathways is likely to grow, at present it is
limited to the a2 repressor; the phytochrome photoreceptor
ofplants, whose light-induced degradation is accompanied by
ubiquitination (10); and cyclins, whose periodic destruction
controls transitions in the cell cycle (11). One difficulty in
establishing whether the degradation of a short-lived protein
requires its conjugation to Ub stems from the fact that,
depending on the relative rates of ubiquitination, deubiquit-
ination, and degradation of the Ub-containing protein, the
steady-state levels of ubiquitinated species may range from
negligible to readily detectable (18). For instance, while the
levels of Ub-phytochrome conjugates in plant cells are high
during phytochrome degradation (10), the steady-state levels
of Ub-a2 conjugates in yeast cells are very low and required
special techniques, such as epitope tagging of Ub, for their
identification. It is therefore possible that other naturally
short-lived proteins whose degradation appears to be inde-
pendent of Ub by criteria such as immunoblotting (4) may
eventually be found to require Ub for proteolysis.
The a2 repressor joins a growing list of known in vivo
acceptors of ubiquitin. These include mammalian histones
H2A and H2B, the actin of insect flight muscle, several
plasma membrane proteins (e.g., the growth hormone recep-
tor), and the plant protein phytochrome (reviewed in refs. 7
and 10). With the exception of a2 and phytochrome, it
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FIG. 3. Overexpression of Ub-R48 inhibits a2 degradation. (A) Pulse-chase analysis of a2 degradation in DBY1829 cells expressing high
levels of wild-type Ub. (B) Same as in A except that cells expressed high levels of the Ub-R48 mutant. (C) Quantitation of an independent set
of pulse-chase experiments. e, Copper-induced cells expressing the Ub-R48 mutant; o, copper-induced cells expressing wild-type Ub.
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FIG. 4. An amino-terminally extended variant of Ub that inhibits Ub-dependent protein degradation also inhibits degradation of a2.
Pulse-chase analysis was performed as described (3). Proteins were extracted from DBY1829 cells carrying plasmids expressing either wild-type
Ub (YEp96) or mycUb (mUb; YEp105) and were precipitated with antibody to a2.
remains unclear whether ubiquitination of these proteins
influences their metabolic stability.
The a2 repressor contains two autonomous degradation
signals that function via genetically distinct proteolytic path-
ways (3). Ubiquitination of a2 has been shown to be essential
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FIG. 5. Evidence for multiple ubiquitination sites in a2. (A)
HR125-5Dalf cells expressing either wild-type Ub (lanes 2 and 3) or
mycUb (mUb; lanes 1 and 4) were pulse-labeled, and extracts were
precipitated with antibody to ac2. These cells also carried a high-copy
plasmid encoding either wild-type a2 protein (lanes 1 and 2) or a2
with Lys Arg substitutions at positions 107 and 109 (lanes 3 and
4). (B) An enlargement of a portion of A that highlights the three
monoubiquitinated species of the wild-type ac2, observed with either
wild-type Ub (lane 2) or mycUb (lane 1). Only two of these species
are seen with the mutant ac2 protein (lanes 3 and 4). The more slowly
migrating species missing in the samples of mutant a2 are indicated
with arrowheads in lanes 1 and 2.
for maximal rates of a2 degradation (see Results). Null mu-
tations in several of the UBC genes, which encode Ub-
conjugating enzymes, inhibit a2 turnover (M.H., S. Jentsch,
and A.V., unpublished results). Use ofthe methods developed
in the present work and the previously isolated S. cerevisiae
mutants defective in a2 degradation (3) should make it pos-
sible to determine whether conjugation ofUb to ac2 is required
for all or only some of the a2-degrading pathways.
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